RE:RE:RE:RE:RE:RE:Meanwhile Verte 's IR departmentWe all have our investment styles and strategies.
back to the issues at hand:
-buyer paid $1.57. Sernova management unable to sustain that level
-many of us have been "misled" by management
-I don't many short term catalysts left. So I guess patience is in order. Perhaps the second tranche of Evotec purchase in August will create some momentum
-I also see glaring issues with governance. This is a one man show. BoD absolutely not independent. No one has shareholders interests in mind. If Chris could replace all retail shareholders with 2 or 3 institutionals, he would. But of course he has not shown he has the competence to do this
this is turning out to be a difficult relationship. Management unhappy with retail investors. Investors not seeing the return they are expecting given the stagnation between 2006 and 2021... and the level of risk.
the Last few weeks were meant to provide an "off ramp" to retail investors. But management was unable to put the right conditions / sequence of events in place.
Amateur hour should be over by now.